Alpro Pharmacy & TCI Gene partner for genetic testing

TCI Gene, a leading genetic testing company, has announced a strategic partnership with Alpro Pharmacy, Malaysia’s renowned pharmacy chain, to offer genetic assessment services to Malaysians.

This initiative aims to provide preventative healthcare options, complementing Alpro Pharmacy’s commitment to comprehensive health solutions.

MyDNA360: Tailored Risk Assessment

The service, named MyDNA360, will launch in April 2024 and offers Malaysians comprehensive genetic assessments for critical health conditions prevalent in the nation.

Genetically inherited diseases pose a significant threat, with 1 in 4 Malaysians succumbing to such illnesses.

The high prevalence of diseases like cancer (1 in 658 cases), type 2 diabetes (15% of the population), and Alzheimer’s disease (projected 312% increase by 2050) underscores the need for preventative measures.

TCI Gene’s genetic assessments utilize globally recognized detection points for high-risk diseases.

Combining genetic knowledge, systems biology, and big data analysis, they leverage a proprietary global genome databank and an AI-powered engine to deliver actionable results for Malaysians.

Their advanced technology has garnered recognition from major Asian healthcare providers, marking a significant step in their Southeast Asian expansion.

Alpro Pharmacy: Shared vision for a healthier Malaysia

Grace Fu, General Manager of TCI Gene, and Ph. Low Swee Siong, Group CEO of Alpro Pharmacy, expressed their enthusiasm for the partnership.

Ph. Low emphasises, “This partnership is a major step forward in promoting proactive health management. By offering affordable genetic testing, we empower Malaysians to make informed decisions about their health and their families’ well-being.”

Fu echoes this sentiment, stating, “Alpro Pharmacy’s dedication to community healthcare aligns perfectly with our vision.

We are confident this collaboration will improve Malaysians’ health through predictive assessment services, contributing to a healthier nation.

We aim to expand this model with international partners and benefit populations across Asia.”

The Alpro Pharmacy and TCI Gene partnership offers Malaysians a powerful tool for proactive healthcare.

By harnessing the power of genetic testing, individuals can take control of their health and make informed decisions for a healthier future.